Effects of Play Based Therapy on Attention Level of Children With Down Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 19, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 3-5 years
- • Gender: Both male and female
- • Children who are currently taking speech therapy sessions with parental involvement.
- • Medically stable children with no severe ongoing health issues that could interfere with their participation in the study.
- Exclusion Criteria:
- • Children with severe sensory impairments
- • Co-morbid neurological conditions that may confound the results
- • Children who received intervention from any other institute
Trial Officials
Aleena Irum, Ms-SLP
Principal Investigator
Riphah International University
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported